Jaguar Health, Inc.

Equities

JAGX

US47010C8881

Market Closed - Nasdaq Other stock markets 02:30:00 12/12/2025 am IST			5-day change	1st Jan Change
1.440 ^USD	+8.27%		+30.91%	-94.30%

24/11	Jaguar Health, Inc. announced that it has received $10.81 million in funding	CI
21/11	Sector Update: Health Care Stocks Softer Late Afternoon	MT

Transcript : Jaguar Health, Inc., Q4 2024 Earnings Call, Mar 31, 2025

Published on 03/31/2025 at 06:00 pm IST

S&P Capital IQ

Presentation Operator Message
Operator (Operator)

Greetings, and welcome to the Jaguar Health Investor Webcast.

Before I turn the call over to management, I'd like to

This article is reserved for subscribers

Unlock the article : SUBSCRIBE!

Already a customer? Log In

Latest news about Jaguar Health, Inc.

24/11	Jaguar Health, Inc. announced that it has received $10.81 million in funding	CI
21/11	Sector Update: Health Care Stocks Softer Late Afternoon	MT
21/11	Sector Update: Health Care	MT
21/11	Jaguar Health's Napo Pharmaceuticals Submits Amended Crofelemer Trial Protocol to FDA	MT
29/11	Jaguar Health, Inc., Q3 2025 Earnings Call, Nov 17, 2025
17/11	Gastrointestinal drugmaker Jaguar Health's Q3 net loss narrows	RE
15/11	Jaguar Health, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025	CI
12/11	Jaguar Health, Inc. announced that it expects to receive $10.81 million in funding	CI
10/10	Jaguar Health, Inc. announced that it has received $0.999951 million in funding from Brown Stone Capital, LTD	CI
04/10	Jaguar Health files for resale of up to 2.6 million shares by selling stockholders - SEC filing	RE
02/10	Jaguar Health says on September 28 entered securities purchase agreement with Brown Stone Capital Limited - SEC filing	RE
28/09	Jaguar Health, Inc. announced that it expects to receive $0.999951 million in funding from Brown Stone Capital, LTD	CI
24/09	Jaguar Health Unit Submits Orphan Drug Status Application to US FDA for Cancer Therapy-Related Diarrhea Drug	MT
10/09	Jaguar Health, Inc. announced that it has received $2.380001 million in funding	CI
09/09	Jaguar Health, Inc. announced that it expects to receive $2.380001 million in funding	CI
14/08	Jaguar Health, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025	CI
14/08	Jaguar Health enters sixth ATM amendment with Ladenburg and Lucid	RE
16/08	Jaguar Health, Inc., Q2 2025 Earnings Call, Aug 14, 2025
25/06	Jaguar Health to Seek European Regulatory Approval for Dog Diarrhea Treatment	MT
11/06	Jaguar Health Establishes First Site for Canalevia-CA1 Field Study	MT
21/05	Jaguar Health Prices Offering of Shares, Warrants	MT
19/05	Jaguar Health, Inc., Q1 2025 Earnings Call, May 15, 2025
15/05	Jaguar Health, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2025	CI
30/04	Jaguar Health, Inc. and Napo Therapeutics Announce Initial Proof-Of-Concept Results	CI
30/04	Jaguar Health, Inc. - Special Call